https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/77Latest Researchhttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6307Inhaled Corticosteroids in COPD and Bronchiectasis: Use Biomarkers Rather Than Disease LabelsMon, 30 Oct 2023 15:51:28 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6307https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6306Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort StudyMon, 30 Oct 2023 15:49:36 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6306https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6305Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysisMon, 30 Oct 2023 15:47:30 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6305https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6304The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCOMon, 30 Oct 2023 15:44:03 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6304https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6303Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis: Analysis of Three Population RegistriesMon, 30 Oct 2023 15:41:20 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6303https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6300Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasisMon, 30 Oct 2023 15:38:48 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6300https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6299Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis RegistriesMon, 30 Oct 2023 15:37:34 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6299https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6298Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trialMon, 30 Oct 2023 15:15:46 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6298https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6297A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafMon, 30 Oct 2023 15:14:44 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6297https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6295Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research CollaborationMon, 30 Oct 2023 15:11:55 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6295https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6294Basic, translational and clinical aspects of bronchiectasis in adultsMon, 30 Oct 2023 15:10:22 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6294https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6293European Respiratory Society statement on airway clearance techniques in adults with bronchiectasisMon, 30 Oct 2023 15:07:52 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6293https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6292The effect of azithromycin on sputum inflammatory markers in bronchiectasisMon, 30 Oct 2023 15:05:26 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6292https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6291Endotypes in bronchiectasis: moving towards precision medicine. A narrative reviewMon, 30 Oct 2023 15:01:16 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6291https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6290Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients' and physiotherapists' practicesMon, 30 Oct 2023 14:59:46 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6290https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6289Low Salivary Secretory Leukocyte Protease Inhibitor Levels Are Related to Airway Pseudomonas aeruginosa Infection in BronchiectasisMon, 30 Oct 2023 14:57:22 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6289https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6288Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and preventionMon, 30 Oct 2023 14:52:03 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6288https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6287Alpha1-Antitrypsin Inherited Variants in Patients With BronchiectasisMon, 30 Oct 2023 14:49:44 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6287https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6286Multimorbidity in bronchiectasis: a systematic scoping reviewMon, 30 Oct 2023 14:48:21 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6286https://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6285Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future ChallengesMon, 30 Oct 2023 14:46:37 GMThttps://bronchiectasis.hicservices.dundee.ac.uk:443/Contents/Item/Display/6285